Article de revue

Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial

Roland W. Sutter, Sunil Bahl, Jagadish M. Deshpande, Harish Verma, Mohammad Ahmad, P. Venugopal, J. Venkateswara Rao, Sharad Agarkhedkar, Sanjay K. Lalwani, Abhishek Kunwar, Raman Sethi, Marina Takane, Lalitendu Mohanty, Arani Chatterjee, T. Jacob John, Hamid Jafari, R. Bruce Aylward

Polio eradication needs a new routine immunisation schedule—three or four doses of bivalent type 1 and type 3 oral poliovirus vaccine (bOPV) and one dose of inactivated poliovirus vaccine (IPV), but no immunogenicity data are available for this schedule. We aimed to assess immunogenicity of this vaccine schedule.

 

Auteurs

Langues

  • Anglais

Année de publication

2015

Journal

The Lancet

Volume

100011

Type

Article de revue

Catégories

  • Prestation de services

Maladies

  • Polio

Pays

  • Inde

Organisations

  • Organisation Mondiale de la Santé (OMS)

Régions de l'OMS

  • Région de l'Asie du Sud-Est

Ajouté par: Moderator

Ajouté le: 2015-12-14 06:53:32

Consultations: 2027

Liens

Ajouter une ressource